Numinus Wellness Inc. NUMI

TOR: NUMI | ISIN: CA67054W1032 14/11/2024

0,080 CAD (-23,81%)

(-23,81%) 14/11/2024

Grafiek Numinus Wellness Inc.

Grafiek Numinus Wellness Inc.

1 dag1d -23,81%
1 week1w 45,45%
1 maand1m 220,00%
3 maanden3m 166,67%
6 maanden6m 14,29%
1 jaar1j -33,33%
5 jaar5j -92,23%

Numinus Wellness Inc. in het nieuws

Toon enkel gratis nieuws

12 augustus 2024 · Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD · Persbericht

11 juli 2024 · Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results · Persbericht

11 juli 2024 · Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024 · Persbericht

24 juni 2024 · Numinus Wellness Announces Resignation of Director · Persbericht

20 juni 2024 · Numinus Wellness Announces Strategic Acquisition of MedBright AI · Persbericht

7 juni 2024 · Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD · Persbericht

1 juni 2024 · Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders · Persbericht

30 mei 2024 · Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy · Persbericht

7 mei 2024 · Numinus Wellness Focused on Boosting Profitability and Expanding Community Support · Persbericht

17 april 2024 · Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003 · Persbericht

Profiel Numinus Wellness Inc.

Gezondheidszorg

Medische/verpleegkundige diensten

Niet-energetische mineralen

Professionele, wetenschappelijke en technische diensten

Testlaboratoria

CEO: Allen Morishita

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe